PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 12:54 AM ET

Sponsor Check › Person

William Link

Related person on Form D filings · address states as listed: CA, FL, WA, OH, NJ, TX · listed Mar 19, 2009 → Sep 3, 2024

29issuers
99Form D filings
2009–2024years listed

Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:56 PM ET · SEC enforcement last checked: not yet

Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.

Key records

The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.

1. Lawsuits

None found in sources searched.

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:56 PM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.

Not yet searched.

Search queued. Results are added automatically; check back later or follow this page to be notified.

3. Bankruptcies

None found in sources searched.

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:56 PM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons are made for sponsors and sponsor groups, not individual people.

5. Money to insiders and sales commissions

1 of 80 offerings reports sales commissions totalling $2,772,796; 1 reports finder's fees totalling $150,000; 11 report proceeds to related persons totalling $3,350,000. (includes amounts the issuer reported as estimates)

SourceOffering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell it
EDGAR ↗Sep 3, 2024 D/A
File 021-509796
$0$0$0None listed on this filing
EDGAR ↗Mar 8, 2024 D/A
File 021-502813
$0$0$0None listed on this filing
EDGAR ↗Jul 13, 2023 D
File 021-486781
$0$0$0None listed on this filing
EDGAR ↗May 26, 2023 D
File 021-482682
$0$0$0None listed on this filing
EDGAR ↗Sep 13, 2022 D
File 021-458709
$0$0$0None listed on this filing
EDGAR ↗Aug 16, 2022 D/A
File 021-443584
$0$0$0None listed on this filing
EDGAR ↗Jun 27, 2022 D/A
File 021-421560
$0$0$0None listed on this filing
EDGAR ↗Nov 19, 2021 D
File 021-421870
$0$0$0None listed on this filing
EDGAR ↗Oct 13, 2021 D/A
File 021-412895
$0$0$0None listed on this filing
EDGAR ↗Oct 1, 2020 D
File 021-376899
$0$0$0None listed on this filing
EDGAR ↗Aug 19, 2020 D/A
File 021-365900
$0$0$0None listed on this filing
EDGAR ↗Mar 12, 2020 D/A
File 021-346015
$0$0$0None listed on this filing
EDGAR ↗Feb 14, 2020 D
File 021-360651
$0$0$0None listed on this filing
EDGAR ↗Jan 30, 2020 D/A
File 021-355808
$0$0$0None listed on this filing
EDGAR ↗Sep 6, 2019 D/A
File 021-346548
$0$0$0None listed on this filing
EDGAR ↗Apr 2, 2019 D
File 021-336244
$0$0$0None listed on this filing
EDGAR ↗Feb 27, 2019 D
File 021-333703
$0$0$0None listed on this filing
EDGAR ↗Feb 14, 2019 D
File 021-332870
$0$0$0None listed on this filing
EDGAR ↗Jan 16, 2019 D/A
File 021-328716
$0$0$0None listed on this filing
EDGAR ↗Dec 21, 2018 D
File 021-328802
$0$0$0None listed on this filing
EDGAR ↗Oct 23, 2018 D
File 021-324130
$0$0$0None listed on this filing
EDGAR ↗Aug 20, 2018 D
File 021-319627
$0$0$0None listed on this filing
EDGAR ↗Aug 17, 2018 D
File 021-319552
$0$0$0None listed on this filing
EDGAR ↗Jul 27, 2018 D
File 021-317976
$0$0$0None listed on this filing
EDGAR ↗Jun 1, 2018 D
File 021-313687
$0$0$0None listed on this filing
EDGAR ↗May 15, 2018 D
File 021-312449
$0$0$0None listed on this filing
EDGAR ↗Apr 19, 2018 D
File 021-310594
$0$0$0None listed on this filing
EDGAR ↗Dec 27, 2017 D/A
File 021-299288
$0$0$0None listed on this filing
EDGAR ↗Oct 25, 2017 D
File 021-297412
$0$0$0None listed on this filing
EDGAR ↗Jul 10, 2017 D
File 021-290279
$0$0$0None listed on this filing
EDGAR ↗May 31, 2017 D/A
File 021-287104
$0$0$0None listed on this filing
EDGAR ↗Apr 3, 2017 D/A
File 021-282032
$0$0$0None listed on this filing
EDGAR ↗Mar 15, 2017 D
File 021-282659
$0$0$0None listed on this filing
EDGAR ↗Feb 8, 2017 D
File 021-280243
$0$0$0None listed on this filing
EDGAR ↗Nov 16, 2016 D
File 021-274614
$0$0$0None listed on this filing
EDGAR ↗Nov 16, 2016 D
File 021-274607
$0$0$0
The Issuer is obligated to pay a management fee to the General Partner (or an affiliate thereof).
None listed on this filing
EDGAR ↗Oct 18, 2016 D
File 021-272762
$0$0$0None listed on this filing
EDGAR ↗Oct 5, 2016 D
File 021-271890
$0$0$0None listed on this filing
EDGAR ↗Aug 24, 2016 D
File 021-269459
$0$0$0None listed on this filing
EDGAR ↗Aug 10, 2016 D
File 021-268648
$0$0$1,000,000
Repayment of promissory note to a director of the Issuer.
None listed on this filing
EDGAR ↗Mar 15, 2016 D
File 021-259339
$0$0$0None listed on this filing
EDGAR ↗Nov 20, 2015 D
File 021-251658
$2,772,796 (est.)$0$0Piper Jaffray & Co. BrokerCheck CRD 665 ↗
EDGAR ↗Jul 23, 2015 D
File 021-244279
$0$0$0None listed on this filing
EDGAR ↗Jan 22, 2015 D
File 021-232710
$0$0$0None listed on this filing
EDGAR ↗Jul 18, 2014 D/A
File 021-200099
$0$150,000$250,000 (est.)None listed on this filing
EDGAR ↗Jun 30, 2014 D/A
File 021-204828
$0$0$0
The Issuers are obligated to pay a management fee to the General Partner (or an affiliate thereof).
None listed on this filing
EDGAR ↗Mar 18, 2014 D
File 021-213802
$0$0$0None listed on this filing
EDGAR ↗Mar 20, 2013 D/A
File 021-186287
$0$0$0None listed on this filing
EDGAR ↗Jan 28, 2013 D
File 021-190878
$0$0$250,000 (est.)None listed on this filing
EDGAR ↗Jan 25, 2013 D
File 021-190823
$0$0$0None listed on this filing
EDGAR ↗Oct 17, 2012 D
File 021-185678
$0$0$250,000 (est.)None listed on this filing
EDGAR ↗Oct 3, 2012 D
File 021-184931
$0$0$0None listed on this filing
EDGAR ↗Aug 10, 2012 D
File 021-182573
$0$0$0None listed on this filing
EDGAR ↗Aug 10, 2012 D
File 021-182535
$0$0$250,000 (est.)None listed on this filing
EDGAR ↗May 14, 2012 D
File 021-178148
$0$0$0None listed on this filing
EDGAR ↗Apr 13, 2012 D
File 021-176710
$0$0$0 (est.)None listed on this filing
EDGAR ↗Mar 23, 2012 D
File 021-175482
$0$0$0None listed on this filing
EDGAR ↗Mar 23, 2012 D
File 021-175486
$0$0$0None listed on this filing
EDGAR ↗Mar 23, 2012 D
File 021-175439
$0$0$0None listed on this filing
EDGAR ↗Mar 23, 2012 D
File 021-175440
$0$0$0None listed on this filing
EDGAR ↗Feb 29, 2012 D
File 021-174152
$0$0$0 (est.)None listed on this filing
EDGAR ↗Feb 29, 2012 D
File 021-174156
$0$0$0 (est.)None listed on this filing
EDGAR ↗Feb 24, 2012 D
File 021-173909
$0$0$0None listed on this filing
EDGAR ↗Jul 29, 2011 D
File 021-163700
$0$0$300,000 (est.)None listed on this filing
EDGAR ↗Jul 29, 2011 D
File 021-163704
$0$0$0 (est.)None listed on this filing
EDGAR ↗May 20, 2011 D
File 021-160157
$0$0$0None listed on this filing
EDGAR ↗May 13, 2011 D
File 021-159829
$0$0$250,000 (est.)None listed on this filing
EDGAR ↗Feb 10, 2011 D
File 021-155170
$0$0$0None listed on this filing
EDGAR ↗Feb 1, 2011 D
File 021-154689
$0$0$0None listed on this filing
EDGAR ↗Dec 30, 2010 D
File 021-152765
$0$0$250,000 (est.)None listed on this filing
EDGAR ↗Dec 30, 2010 D
File 021-152783
$0$0$250,000 (est.)None listed on this filing
EDGAR ↗Sep 23, 2010 D
File 021-148086
$0$0$0None listed on this filing
EDGAR ↗Sep 7, 2010 D
File 021-147339
$0$0$250,000 (est.)None listed on this filing
EDGAR ↗Sep 2, 2010 D
File 021-147266
$0$0$50,000 (est.)None listed on this filing
EDGAR ↗Jul 13, 2010 D/A
File 021-66427
$0$0$0None listed on this filing
EDGAR ↗Jun 11, 2010 D
File 021-143333
$0$0$0None listed on this filing
EDGAR ↗Apr 27, 2010 D
File 021-141171
$0$0$0None listed on this filing
EDGAR ↗Apr 6, 2010 D
File 021-140208
$0$0$0None listed on this filing
EDGAR ↗Mar 27, 2009 D
File 021-117391
$0$0$0None listed on this filing
EDGAR ↗Mar 19, 2009 D
File 021-54969
$0$0$0None listed on this filing

As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Appears on these filings

SourceIssuerRoleFiledFormOfferingSoldInvestorsMin. investment
EDGAR ↗ViaLase, Inc.DirectorSep 3, 2024D/A$45,181,755
similar: $829,831–$9,999,998
$45,181,75515
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗ViaLase, Inc.DirectorApr 5, 2024D$41,031,754
similar: $829,831–$9,999,998
$38,157,8126
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗ViaLase, Inc.DirectorMar 8, 2024D/A$3,500,000
similar: $829,831–$9,999,998
$3,500,0003
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗ViaLase, Inc.DirectorJan 18, 2024D$2,300,000
similar: $829,831–$9,999,998
$2,300,0003
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗TearClear Corp.DirectorJul 13, 2023D$15,961,748
similar: $1,694,259–$16,000,000
$11,764,26270
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗LENSAR, Inc.DirectorMay 26, 2023D$20,000,000
similar: $829,831–$9,999,998
$20,000,0001
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Neurolens, Inc.DirectorSep 13, 2022D$67,642,795
similar: $2,000,000–$19,999,994
$67,642,79531
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗TearClear Corp.DirectorAug 16, 2022D/A$10,000,000
similar: $1,694,259–$16,000,000
$5,900,00043
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗Neurolens, Inc.DirectorJun 27, 2022D/A$15,000,000
similar: $2,000,000–$19,999,994
$14,700,00027
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗TearClear Corp.DirectorApr 27, 2022D$10,000,000
similar: $1,694,259–$16,000,000
$5,000,00040
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗ViaLase, Inc.DirectorNov 19, 2021D$27,287,919
similar: $829,831–$9,999,998
$27,287,91925
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Neurolens, Inc.DirectorNov 17, 2021D$12,000,000
similar: $2,000,000–$19,999,994
$12,000,0009
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Allegro Ophthalmics, LLCDirectorOct 13, 2021D/A$6,746,652
similar: $1,694,259–$16,000,000
$5,423,2846
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗Allegro Ophthalmics, LLCDirectorSep 10, 2021D$6,746,652
similar: $1,694,259–$16,000,000
$4,599,9901
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗Allegro Ophthalmics, LLCDirectorOct 1, 2020D$8,324,042
similar: $1,694,259–$16,000,000
$8,324,04215
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗TearClear Corp.DirectorAug 19, 2020D/A$25,967,377
similar: $1,694,259–$16,000,000
$22,346,50351
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗TearClear Corp.DirectorJul 23, 2020D/A$25,967,377
similar: $1,694,259–$16,000,000
$22,246,50450
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗TearClear Corp.DirectorApr 28, 2020D$25,967,377
similar: $1,694,259–$16,000,000
$15,779,67839
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗Neurolens, Inc.DirectorMar 12, 2020D/A$23,999,998
similar: $2,000,000–$19,999,994
$23,819,97224
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗TearClear Corp.DirectorFeb 14, 2020D$3,000,000
similar: $1,694,259–$16,000,000
$2,790,00032
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗Allegro Ophthalmics, LLCDirectorJan 30, 2020D/A$6,738,545
similar: $1,694,259–$16,000,000
$5,335,97311
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗Allegro Ophthalmics, LLCDirectorDec 18, 2019D$6,738,545
similar: $1,694,259–$16,000,000
$5,000,0001
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗Neurolens, Inc.DirectorDec 16, 2019D/A$23,999,998
similar: $2,000,000–$19,999,994
$22,994,97920
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Equinox Ophthalmic, Inc.DirectorSep 6, 2019D/A$21,999,998
similar: $1,100,015–$10,001,163
$13,422,10011
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Equinox Ophthalmic, Inc.DirectorAug 14, 2019D$21,999,998
similar: $1,100,015–$10,001,163
$13,389,97910
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Neurolens, Inc.DirectorAug 7, 2019D$23,999,998
similar: $2,000,000–$19,999,994
$15,174,9957
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗ViaLase, Inc.DirectorApr 2, 2019D$8,139,570
similar: $829,831–$9,999,998
$8,139,5707
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Oyster Point Pharma, Inc.DirectorFeb 27, 2019D$92,999,999
similar: $1,694,259–$16,000,000
$84,999,9857
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗TearClear Corp.DirectorFeb 14, 2019D$5,000,000
similar: $2,000,000–$19,999,994
$4,999,99922
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Allegro Ophthalmics, LLCDirectorJan 16, 2019D/A$13,477,089
similar: $1,694,259–$16,000,000
$10,271,60614
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗SECOND SIGHT MEDICAL PRODUCTS INCDirectorDec 21, 2018D$2,999,991
similar: $2,000,000–$19,999,994
$2,999,9912
similar: 2–16
$1,000,000
similar: $10,000–$50,000
EDGAR ↗Allegro Ophthalmics, LLCDirectorDec 21, 2018D$13,477,089
similar: $1,694,259–$16,000,000
$10,000,0001
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗SECOND SIGHT MEDICAL PRODUCTS INCDirectorOct 23, 2018D$3,997,718
similar: $2,000,000–$19,999,994
$3,997,7182
similar: 2–16
$1,000,000
similar: $10,000–$50,000
EDGAR ↗AcuFocus, Inc.DirectorAug 20, 2018D$26,000,000
similar: $2,000,000–$19,999,994
$23,974,00015
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗SECOND SIGHT MEDICAL PRODUCTS INCDirectorAug 17, 2018D$5,000,000
similar: $2,000,000–$19,999,994
$5,000,0002
similar: 2–16
$1,000,000
similar: $10,000–$50,000
EDGAR ↗Prelude CorpDirectorJul 27, 2018D$8,999,991
similar: $2,000,000–$19,999,994
$8,999,9917
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Edwards Lifesciences CorpDirectorJun 1, 2018D$34,869,330
similar: $2,000,000–$19,999,994
$34,869,33025
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗CorneaGen Inc.DirectorMay 15, 2018D$2,000,000
similar: $829,831–$9,999,998
$2,000,0001
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗CorneaGen Inc.DirectorApr 19, 2018D$5,000,000
similar: $829,831–$9,999,998
$5,000,0001
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Neurolens, Inc.DirectorDec 27, 2017D/A$14,000,000
similar: $2,000,000–$19,999,994
$13,121,90535
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Oyster Point Pharma, Inc.DirectorOct 25, 2017D$43,125,784
similar: $1,694,259–$16,000,000
$28,614,8008
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗Allegro Ophthalmics, LLCDirectorJul 10, 2017D$13,668,480
similar: $1,694,259–$16,000,000
$10,721,50817
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗TearClear Corp.DirectorMay 31, 2017D/A$4,631,151
similar: $2,000,000–$19,999,994
$4,631,14911
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗TearClear Corp.DirectorMay 19, 2017D$4,631,151
similar: $2,000,000–$19,999,994
$2,386,1499
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗RxSight, Inc.DirectorApr 3, 2017D/A$77,499,999
similar: $829,831–$9,999,998
$49,975,20262
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Prelude CorpDirectorMar 15, 2017D$5,499,998
similar: $2,000,000–$19,999,994
$5,499,9987
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗RxSight, Inc.DirectorMar 8, 2017D$77,499,999
similar: $829,831–$9,999,998
$38,660,64328
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Edwards Lifesciences CorpDirectorFeb 8, 2017D$272,371,872
similar: $2,000,000–$19,999,994
$272,371,87225
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Versant Venture V AIV Feeder Holdings, L.P.Director
Manager of the General Partner of the Issuer
Nov 16, 2016D$5,342,623
similar: $155,000–$5,250,000
$5,342,6237
similar: 4–27
No minimum reported
similar: $1,000–$100,000
EDGAR ↗Versant Venture V AIV, L.P.Director
Manager of the General Partner of the Issuer
Nov 16, 2016D$21,939,788
similar: $155,000–$5,250,000
$21,939,78832
similar: 4–27
No minimum reported
similar: $1,000–$100,000
EDGAR ↗CorneaGen Inc.DirectorOct 18, 2016D$10,000,000
similar: $829,831–$9,999,998
$10,000,0001
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗AcuFocus, Inc.DirectorOct 5, 2016D$74,924,639
similar: $2,000,000–$19,999,994
$74,924,63919
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗AcuFocus, Inc.DirectorAug 24, 2016D$2,000,000
similar: $2,000,000–$19,999,994
$2,000,00015
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗AEON Biopharma, Inc.Executive Officer, Director
Chairman of the Board
Aug 10, 2016D$55,000,000
similar: $829,831–$9,999,998
$5,500,0005
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Prelude CorpDirectorMar 15, 2016D$3,000,000
similar: $2,000,000–$19,999,994
$2,150,0024
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗AEON Biopharma, Inc.Executive Officer, Director
Chairman of the Board
Nov 20, 2015D$150,000,000
similar: $829,831–$9,999,998
$80,060,11828
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗OneFocus Vision, Inc.DirectorJul 23, 2015D$2,201,285
similar: $829,831–$9,999,998
$2,201,2854
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗AEON Biopharma, Inc.Executive Officer, Director
Chairman of the Board
Jan 22, 2015D$40,500,005
similar: $829,831–$9,999,998
$27,000,0155
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗SECOND SIGHT MEDICAL PRODUCTS INCDirectorJul 18, 2014D/A$12,000,000
similar: $2,000,000–$19,999,994
$11,000,0005
similar: 2–16
$1,000
similar: $10,000–$50,000
EDGAR ↗Versant Venture Capital V, L.P.Director
Managing Director of the General Partner of the Issuers
Jun 30, 2014D/A$300,000,000
similar: $155,000–$5,250,000
$295,515,30686
similar: 4–27
No minimum reported
similar: $1,000–$100,000
EDGAR ↗SECOND SIGHT MEDICAL PRODUCTS INCDirectorJun 25, 2014D/A$10,500,000
similar: $2,000,000–$19,999,994
$6,000,0000
similar: 2–16
$1,000
similar: $10,000–$50,000
EDGAR ↗Oculeve, Inc.DirectorMar 18, 2014D$16,649,997
similar: $829,831–$9,999,998
$16,649,9978
similar: 2–15
$1
similar: $10,000–$54,310
EDGAR ↗Versant Venture Capital V, L.P.Director
Managing Director of the General Partner of the Issuers
Oct 18, 2013D$250,000,000
similar: $500,000–$16,420,250
$00
similar: 2–28
No minimum reported
similar: $5,000–$100,000
EDGAR ↗SECOND SIGHT MEDICAL PRODUCTS INCDirectorJul 23, 2013D$10,500,000$00$1,000
EDGAR ↗Oculeve, Inc.DirectorMar 20, 2013D/A$7,592,976$7,590,4769No minimum reported
EDGAR ↗SECOND SIGHT MEDICAL PRODUCTS INCDirectorJan 28, 2013D$25,000,000$00$1,000
EDGAR ↗GLAUKOS CorpDirectorJan 25, 2013D$30,000,002$30,000,00220No minimum reported
EDGAR ↗Oculeve, Inc.DirectorOct 30, 2012D$7,565,476$7,565,4768No minimum reported
EDGAR ↗SECOND SIGHT MEDICAL PRODUCTS INCDirectorOct 17, 2012D$5,000,000$00$1,000
EDGAR ↗GLAUKOS CorpDirectorOct 3, 2012D$6,000,000$6,000,00011No minimum reported
EDGAR ↗GLAUKOS CorpDirectorAug 10, 2012D$4,500,000$4,500,00014No minimum reported
EDGAR ↗SECOND SIGHT MEDICAL PRODUCTS INCDirectorAug 10, 2012D$5,000,000$00$1,000
EDGAR ↗NEOVISTA INCExecutive Officer, DirectorMay 14, 2012D$6,273,000$5,185,05515$1
EDGAR ↗SECOND SIGHT MEDICAL PRODUCTS INCDirectorApr 13, 2012D$5,000,000$00$2,000
EDGAR ↗Versant Side Fund II, LPDirector
Managing Director of the General Partner of the Issuer
Mar 23, 2012D$3,575,000$3,575,00016No minimum reported
EDGAR ↗VERSANT AFFILIATES FUND I-A LPDirector
Managing Director of the General Partner of the Issuer
Mar 23, 2012D$5,175,000$5,175,00037No minimum reported
EDGAR ↗VERSANT SIDE FUND I LPDirector
Managing Director of the General Partner of the Issuer
Mar 23, 2012D$5,000,000$5,000,00018No minimum reported
EDGAR ↗VERSANT AFFILIATES FUND I-B LPDirector
Managing Director of the General Partner of the Issuer
Mar 23, 2012D$11,625,000$11,625,00072No minimum reported
EDGAR ↗SECOND SIGHT MEDICAL PRODUCTS INCDirectorFeb 29, 2012D$2,000,000$2,000,0000$2,000
EDGAR ↗SECOND SIGHT MEDICAL PRODUCTS INCDirectorFeb 29, 2012D$2,000,000$2,000,0000$2,000
EDGAR ↗NEOVISTA INCDirectorFeb 24, 2012D$1,001,000$1,000,45816$1
EDGAR ↗SECOND SIGHT MEDICAL PRODUCTS INCDirectorJul 29, 2011D$16,150,000$00$2,000
EDGAR ↗SECOND SIGHT MEDICAL PRODUCTS INCDirectorJul 29, 2011D$5,000,000$00$10,000
EDGAR ↗Cameron Health, Inc.DirectorMay 20, 2011D$107,178,246$82,670,84062$1
EDGAR ↗SECOND SIGHT MEDICAL PRODUCTS INCDirectorMay 13, 2011D$6,300,000$3,000,0005$1,000
EDGAR ↗NEOVISTA INCDirectorFeb 10, 2011D$37,879,999$33,784,54519$1
EDGAR ↗GLAUKOS CorpDirectorFeb 1, 2011D$29,500,003$29,500,00318No minimum reported
EDGAR ↗SECOND SIGHT MEDICAL PRODUCTS INCDirectorDec 30, 2010D$3,800,000$1,900,00010$1,000
EDGAR ↗SECOND SIGHT MEDICAL PRODUCTS INCDirectorDec 30, 2010D$3,500,000$3,500,00010$1,000
EDGAR ↗GLAUKOS CorpDirectorSep 23, 2010D$6,000,392$6,000,39211No minimum reported
EDGAR ↗SECOND SIGHT MEDICAL PRODUCTS INCDirectorSep 7, 2010D$3,000,000$1,500,00010$1,000
EDGAR ↗SECOND SIGHT MEDICAL PRODUCTS INCDirectorSep 2, 2010D$5,000,000$5,000,00019$1,000
EDGAR ↗Inogen IncDirectorJul 13, 2010D/A$10,000,000$9,645,9968No minimum reported
EDGAR ↗NEOVISTA INCDirectorJun 11, 2010D$12,012,000$3,203,20018$1
EDGAR ↗NEOVISTA INCDirectorApr 27, 2010D$3,003,000$3,003,00017$1
EDGAR ↗DOSE Medical CorpDirectorApr 6, 2010D$74,492$74,49243No minimum reported
EDGAR ↗Inogen IncDirectorMar 2, 2010D$10,000,000$4,522,9987No minimum reported
EDGAR ↗LENSX LASERS INCDirectorMar 27, 2009D$22,360,578$22,360,57814No minimum reported
EDGAR ↗NEOVISTA INCDirectorMar 19, 2009D$18,000,000$17,159,89018No minimum reported

Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.

"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years (6 industry/exemption sets on this page); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other listings under the same name

Separate person records under the same name, not combined with this page. Each line says whether it is listed on an issuer this record is also listed on (a second identifier); where it is not, it could be the same person or a different one.

  • William J. Link — address state TX, 1 issuer, Dec 4, 2009 → Oct 14, 2010 · no shared issuer found

Connections as of Oct 23, 2026, 5:45 PM ET

Listed alongside — 40 names on the same filings (4 management entities, 36 people)

People and management entities the issuers listed as related persons on the same Form D filings as William Link. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.

  • Versant Ventures V, LLC entity — 4 shared filings (3 issuers) · role as listed: Director
  • Versant Ventures I, LLC entity — 3 shared filings (3 issuers) · role as listed: Director
  • Versant Ventures II, LLC entity — 1 shared filing (1 issuer) · role as listed: Director
  • Thomas Bender entity — 1 shared filing (1 issuer) · role as listed: Director
  • Gregg Williams — 18 shared filings (1 issuer) · role as listed: Director
  • AARON MENDELSOHN — 18 shared filings (1 issuer) · role as listed: Director · also listed on 2 other issuers
  • Robert Greenberg — 16 shared filings (1 issuer) · roles as listed: Executive Officer, Director · also listed on 4 other issuers
  • ALFRED MANN — 16 shared filings (1 issuer) · role as listed: Director
  • KATHY LONDON — 16 shared filings (1 issuer) · role as listed: Executive Officer
  • Jeffry K. Weinhuff — 12 shared filings (2 issuers) · role as listed: Director · also listed on 5 other issuers
  • TYLER STOWATER — 11 shared filings (2 issuers) · role as listed: Director · also listed on 32 other issuers
  • Scott Cooper — 10 shared filings (2 issuers) · role as listed: Executive Officer · also listed on 1 other issuer
  • Tom Fogerty — 10 shared filings (1 issuer) · role as listed: Director
  • J. Andy Corley — 10 shared filings (3 issuers) · roles as listed: Director, Executive Officer · also listed on 2 other issuers
  • Richard Heinick — 10 shared filings (1 issuer) · role as listed: Director · also listed on 2 other issuers
  • Kevin Hershfield — 9 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Richard Lindstrom — 9 shared filings (4 issuers) · role as listed: Director · also listed on 13 other issuers
  • Olav B. Bergheim — 8 shared filings (2 issuers) · roles as listed: Director, Executive Officer · also listed on 12 other issuers
  • Ronald Kurtz — 8 shared filings (2 issuers) · roles as listed: Executive Officer, Director
  • John Park — 8 shared filings (1 issuer) · roles as listed: Executive Officer, Director · also listed on 8 other issuers
  • Hampar Karageozian — 8 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Vicken Karageozian — 8 shared filings (1 issuer) · roles as listed: Executive Officer, Director · also listed on 1 other issuer
  • Melvin Sarayba — 8 shared filings (1 issuer) · role as listed: Executive Officer
  • Tom Frinzi — 8 shared filings (2 issuers) · role as listed: Director
  • Richard Harrison — 7 shared filings (3 issuers) · role as listed: Executive Officer · also listed on 2 other issuers
  • Davis Corley — 7 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Steve Pazol — 7 shared filings (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • Marc Carlson — 7 shared filings (1 issuer) · role as listed: Director
  • Steve T. Kirby — 7 shared filings (1 issuer) · role as listed: Director
  • Gilbert H. Kliman — 6 shared filings (2 issuers) · role as listed: Director · also listed on 5 other issuers
  • John Hendrick — 6 shared filings (1 issuer) · roles as listed: Executive Officer, Director · also listed on 2 other issuers
  • Steven Waite — 6 shared filings (1 issuer) · role as listed: Director · also listed on 5 other issuers
  • Stephen Martin — 6 shared filings (2 issuers) · role as listed: Director · also listed on 1 other issuer
  • Thomas W. Burns — 6 shared filings (2 issuers) · roles as listed: Executive Officer, Director
  • TOM FOGARTY — 6 shared filings (1 issuer) · role as listed: Director · also listed on 2 other issuers
  • Tim Petersen — 6 shared filings (1 issuer) · role as listed: Director
  • Tibor Juhasz — 6 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Ross Jaffe — 6 shared filings (5 issuers) · role as listed: Director · also listed on 8 other issuers
  • Samuel Colella — 6 shared filings (5 issuers) · role as listed: Director · also listed on 6 other issuers
  • Ryan Schwarz — 6 shared filings (1 issuer) · role as listed: Director · also listed on 13 other issuers

Other offering types (Regulation A and Regulation Crowdfunding)

None found in sources searched.

Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.

Export this report as PDF (members · included free during the launch period)

Change history

No corrections have been requested for this page.

Facts from public records only, each linked to its source. No ratings, no opinions. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when William Link appears on a new Form D, or when a court case or SEC action is matched to them. See plans →